Target intelligence / Profile preview

RDM1 pseudogene 4 (RDM1P4)

Target
RDM1P4
Molecular classification
Other (Pseudogene)
01

Overview

RDM1 pseudogene 4 (RDM1P4) is classified as a *processed pseudogene* located in the human genome. Pseudogenes are segments of DNA similar to known genes but are generally non-functional in terms of protein-coding due to mutations, truncations, or absence of regulatory elements. While the protein-coding RDM1 gene (RAD52 motif-containing protein 1) plays important roles in DNA damage repair, cell cycle regulation, and cancer biology[1], RDM1P4 does not encode a functional protein. Like other human pseudogenes, RDM1P4 could potentially regulate gene expression at the RNA level, for example by acting as a *competitive endogenous RNA (ceRNA)*, miRNA decoy, or modulator of its parental gene[3][9][10]. However, there is no direct experimental evidence for RDM1P4 having such functions, nor is it an established therapeutic or diagnostic target. Therefore, RDM1P4 is not considered a classic drug target, receptor, enzyme, or transporter; its direct clinical or therapeutic relevance remains unknown. Key points: - RDM1P4 is a pseudogene, not a protein-coding gene or druggable target. - No specific functional, disease, or drug interaction data are available for this pseudogene. - Its *putative* functions (if any) would likely be based on general mechanisms attributed to pseudogenes, such as RNA-based regulation. - The protein-coding parent gene RDM1 is biologically significant (cancer, DNA repair)[1], but this does not extend to RDM1P4 itself in current scientific knowledge. If you need a canonical, protein-coding therapeutic target, you may be searching for **RAD52 motif-containing protein 1 (RDM1)** rather than this pseudogene.

Other names
RDM1P4RDM1 pseudogene 4
02

Biological functions

Other (Possible regulatory functions at the RNA level, e.g., acting as a competitive endogenous RNA, miRNA decoy, or regulator of parental gene expression—this is typical for pseudogenes but not specifically demonstrated for RDM1P4)
03

Disease associations

Other (No direct evidence for a disease association for RDM1P4; note that parental gene RDM1 is implicated as a prognostic marker and potential regulator in cancer[1], but this is not established for the pseudogene RDM1P4)

Beyond the preview

Go deeper on RDM1 pseudogene 4 (RDM1P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RDM1 pseudogene 4 (RDM1P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call